• The Weight-Loss Shots Semaglutide and Tirzepatide: Controversy and Understanding their Use

  • May 30 2023
  • Duración: 30 m
  • Podcast

The Weight-Loss Shots Semaglutide and Tirzepatide: Controversy and Understanding their Use Por arte de portada

The Weight-Loss Shots Semaglutide and Tirzepatide: Controversy and Understanding their Use

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • This presentation is on the medications semaglutide and tirzepatide , prescribed under brand names such as Ozempic, Wegovy and Monjaro, and others, some of which are in development. These drugs are GLP-1 agonist medications most commonly used for the treatment of type 2 diabetes, but more recently it’s been in the spotlight as a medication for weight loss, causing controversy, misunderstanding, questions and significant shortages of the medication.

    Dr. DeSarbo will briefly look at these medications from all perspectives including their use in diabetes, as a weight loss drug for the medical definition of obesity, and their potential impact and fallout with the eating disorder population.
    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre The Weight-Loss Shots Semaglutide and Tirzepatide: Controversy and Understanding their Use

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles